"Why is it that patients who take prednisone, insulin...and a myriad of other medications daily or regularly to manage ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers say the condition occurs in ...

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

For years, Texans living with conditions like PTSD, neuropathy, cancer and spasticity have had limited treatment options. Now ...

The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Long-term cannabis users may be unknowingly at risk for a painful and costly condition called cannabinoid hyperemesis syndrome, which causes severe nausea, vomiting, and abdominal pain. A new study ...

Study shows that cannabidiol (CBD) enhances endurance exercise in mice by reshaping gut microbiota, boosting mitochondrial ...

Moroccan authorities are intensifying efforts to regulate and expand the production of pharmaceutical drugs derived from cannabis, with a series of high-level meetings and site visits taking place ...

The drug fenfluramine has been recommended by the National Institute for Health and Care Excellence (NICE) for children with ...

NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...